ITGB5, associated with focal adhesion, immune suppression, and signaling pathways critical in cancer progression and poor survival outcomes in various cancers (25–28), is less studied in CC but is reported to activate the focal adhesion pathway, inducing cisplatin resistance in CC cells (29) . Here, ITGB5 is linked to cancer.